<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Adv Drug Deliv Rev</journal-id><journal-id journal-id-type="iso-abbrev">Adv Drug Deliv Rev</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Advanced drug delivery reviews</journal-title></journal-title-group><issn pub-type="ppub">0169-409X</issn><issn pub-type="epub">1872-8294</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10589123</article-id><article-id pub-id-type="pmcid-ver">PMC10589123.1</article-id><article-id pub-id-type="pmcaid">10589123</article-id><article-id pub-id-type="pmcaiid">10589123</article-id><article-id pub-id-type="manuscript-id">NIHMS1935821</article-id><article-id pub-id-type="pmid">35489652</article-id><article-id pub-id-type="doi">10.1016/j.addr.2022.114311</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1935821</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1935821</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Laser Ablation: Heating up the Anti-Tumor Response in the Intracranial Compartment</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lerner</surname><given-names initials="EC">Emily C.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Edwards</surname><given-names initials="RM">Ryan M</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilkinson</surname><given-names initials="DS">Daniel S.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fecci</surname><given-names initials="PE">Peter E.</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Duke Medical School, Duke University Medical Center, Durham, NC, United States</aff><aff id="A2"><label>2</label>Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States</aff><author-notes><corresp id="CR1"><label>*</label>Correspondence: Peter E. Fecci, <email>peter.fecci@duke.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>27</day><month>4</month><year>2022</year></pub-date><volume>185</volume><issue-id pub-id-type="pmc-issue-id">447688</issue-id><fpage>114311</fpage><lpage>114311</lpage><pub-history><event event-type="nihms-submitted"><date><day>14</day><month>10</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>21</day><month>10</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>21</day><month>10</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 15:25:31.883"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1935821.pdf"/><abstract id="ABS1"><p id="P1">Immunotherapies, such as immune checkpoint inhibition (ICI), have had limited success in treating intracranial malignancies. These failures are due partly to the restrictive blood-brain-barrier (BBB), the profound tumor-dependent induction of local and systemic immunosuppression, and immune evasion exhibited by these tumors. Therefore, novel approaches must be explored that aim to overcome these stringent barriers.</p><p id="P2">LITT is an emerging treatment for brain tumors that utilizes thermal ablation to kill tumor cells. LITT provides an additional therapeutic benefit by synergizing with ICI and systemic chemotherapies to strengthen the anti-tumor immune response. This synergistic relationship involves transient disruption of the BBB and local augmentation of immune function, culminating in increased CNS drug penetrance and improved anti-tumor immunity.</p><p id="P3">In this review, we will provide an overview of the challenges facing immunotherapy for brain tumors, and discuss how LITT may synergize with the endogenous anti-tumor response to improve the efficacy of ICI.</p></abstract><kwd-group><kwd>LITT</kwd><kwd>laser interstitial thermal therapy</kwd><kwd>immunotherapy</kwd><kwd>checkpoint inhibition</kwd><kwd>checkpoint blockade</kwd><kwd>glioma</kwd><kwd>glioblastoma</kwd><kwd>brain metastases</kwd><kwd>intracranial tumors</kwd><kwd>blood brain barrier</kwd><kwd>hyperthermia</kwd><kwd>anti-tumor immunity</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>